Skip to main content
custom logo
Does Exenatide reduce non-motor symptoms in Parkinson’s disease?
Chair Professor Patrik Brundin, with fellow panellists Tom Foltynie from UCL in London, who led the exenatide trial, Nigel Greig and Dimitrios Kapogiannis from the NIA (National Institute on Aging) and exenatide trial participant Penny Kustow, will discuss the recent paper “What effects might exenatide have on non-motor symptoms in Parkinson’s disease: A post hoc analysis”, by Dr Dilan Athauda et al.

Jun 19, 2018 5:30 PM in London

custom image
Webinar is over, you can not register now. If you have any questions, please contact Webinar host: Julia Jockelson.